CRBP
Corbus Pharmaceuticals Holdings, Inc.$8.12-0.11 (-1.33%)Prev Close$8.24·MCap$152.7M·P/E—·Vol391.1K·Yield—
▲
Buys (12M)
2
$126.3K
▼
Sells (12M)
18
$1.47M
◆
Net Activity
Net Seller
$1.35M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Corbus Pharmaceuticals Holdings, Inc. (CRBP) has been dominated by selling, with 2 insider purchases totaling $126.3K and 18 insider sales totaling $1.47M. The most recent insider transaction was by Saxena Nishant C (officer: Chief Business Officer), who purchased $25.0K worth of shares on Aug 12, 2026. Corbus Pharmaceuticals Holdings, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $152.7M.
CRBP Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Saxena Nishant C | officer: Chief Business Officer | Buy | 2,600 | $9.63 | $25.0K | 77,900 |
| Aug 10, 2026 | Moran Sean F. | officer: Chief Financial Officer | Sell | 12,000 | $10.08 | $121.0K | 84,694 |
| Aug 10, 2026 | Cohen Yuval | director, officer: Chief Executive Officer | Sell | 17,000 | $10.08 | $171.4K | 157,316 |
| Jun 11, 2026 | Jenkins John Kenneth | director | Sell | 4,800 | $7.91 | $38.0K | 3,833-56% |
| Jun 11, 2026 | Kung Winston | director | Sell | 2,026 | $7.91 | $16.0K | 12,140 |
| Jun 11, 2026 | Altmeyer Anne | director | Sell | 2,412 | $7.91 | $19.1K | 7,579 |
| Jun 3, 2026 | Saxena Nishant C | officer: Chief Business Officer | Buy | 13,500 | $7.50 | $101.2K | 75,300 |
| Feb 18, 2026 | Cohen Yuval | director, officer: Chief Executive Officer | Sell | 13,871 | $7.78 | $108.0K | 174,316 |
| Feb 18, 2026 | Hodgson Ian | officer: Chief Operating Officer | Sell | 847 | $7.38 | $6.3K | 51,080 |
| Feb 18, 2026 | Moran Sean F. | officer: Chief Financial Officer | Sell | 4,701 | $7.78 | $36.6K | 96,694 |
| Feb 17, 2026 | Hodgson Ian | Chief Operating Officer | Sell | 847 | $7.38 | $6.3K | 0 |
| Feb 13, 2026 | Cohen Yuval | Chief Executive Officer | Sell | 13,871 | $7.78 | $108.0K | 0 |
| Feb 13, 2026 | Moran Sean F. | Chief Financial Officer | Sell | 4,701 | $7.78 | $36.6K | 0 |
| Feb 4, 2026 | Hodgson Ian | officer: Chief Operating Officer | Sell | 2,415 | $8.09 | $19.5K | 51,927 |
| Feb 4, 2026 | Smethurst Dominic | officer: Chief Medical Officer | Sell | 3,285 | $8.09 | $26.6K | 95,887 |
| Feb 3, 2026 | Hodgson Ian | Chief Operating Officer | Sell | 2,415 | $8.09 | $19.5K | 0 |
| Feb 3, 2026 | Smethurst Dominic | Chief Medical Officer | Sell | 3,285 | $8.09 | $26.6K | 0 |
| Oct 24, 2025 | Cohen Yuval | Chief Executive Officer | Sell | 27,633 | $17.05 | $471.2K | 0 |
| Oct 24, 2025 | Moran Sean F. | Chief Financial Officer | Sell | 12,981 | $17.02 | $220.9K | 0 |
| Oct 20, 2025 | Altmeyer Anne | Director | Sell | 1,060 | $20.50 | $21.7K | 0 |
| May 30, 2025 | Altmeyer Anne | Director | Sell | 1,392 | $7.25 | $10.1K | 0 |
| May 30, 2025 | Jenkins John Kenneth | Director | Sell | 2,783 | $7.35 | $20.5K | 0 |
| Mar 6, 2025 | Smethurst Dominic | Chief Medical Officer | Sell | 6,393 | $6.78 | $43.3K | 0 |
| Feb 14, 2025 | Cohen Yuval | Chief Executive Officer | Sell | 7,134 | $8.76 | $62.5K | 0 |
| Feb 14, 2025 | Moran Sean F. | Chief Financial Officer | Sell | 2,792 | $8.76 | $24.4K | 0 |
| Jun 14, 2024 | Cohen Yuval | Chief Executive Officer | Sell | 63,358 | $46.57 | $2.95M0.5% OS | 0 |
| Jun 14, 2024 | Moran Sean F. | Chief Financial Officer | Sell | 18,043 | $47.88 | $863.8K | 0 |
| Aug 10, 2022 | Cohen Yuval | Chief Executive Officer | Buy | 3,800 | $0.26 | $1.0K | 0 |
| Aug 10, 2022 | Millian Craig Stuart | Chief Operating Officer | Buy | 5,000 | $0.25 | $1.3K | 0 |
| Aug 10, 2022 | Moran Sean F. | Chief Financial Officer | Buy | 20,000 | $0.26 | $5.2K | 0 |
| May 16, 2022 | Cohen Yuval | Chief Executive Officer | Buy | 10,500 | $0.25 | $2.6K | 0 |
| May 16, 2022 | Moran Sean F. | Chief Financial Officer | Buy | 12,000 | $0.30 | $3.6K | 0 |
| Mar 10, 2022 | Millian Craig Stuart | Chief Operating Officer | Buy | 10,000 | $0.37 | $3.7K | 0 |
| Mar 10, 2022 | Moran Sean F. | Chief Financial Officer | Buy | 15,000 | $0.37 | $5.5K | 0 |
| Mar 9, 2022 | Cohen Yuval | Chief Executive Officer | Buy | 8,600 | $0.37 | $3.2K | 0 |
CRBP Insider Buying Activity
The following table shows recent insider purchases of Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Saxena Nishant C | officer: Chief Business Officer | Buy | 2,600 | $9.63 | $25.0K | 77,900 |
| Jun 3, 2026 | Saxena Nishant C | officer: Chief Business Officer | Buy | 13,500 | $7.50 | $101.2K | 75,300 |
| Aug 10, 2022 | Cohen Yuval | Chief Executive Officer | Buy | 3,800 | $0.26 | $1.0K | 0 |
| Aug 10, 2022 | Millian Craig Stuart | Chief Operating Officer | Buy | 5,000 | $0.25 | $1.3K | 0 |
| Aug 10, 2022 | Moran Sean F. | Chief Financial Officer | Buy | 20,000 | $0.26 | $5.2K | 0 |
| May 16, 2022 | Cohen Yuval | Chief Executive Officer | Buy | 10,500 | $0.25 | $2.6K | 0 |
| May 16, 2022 | Moran Sean F. | Chief Financial Officer | Buy | 12,000 | $0.30 | $3.6K | 0 |
| Mar 10, 2022 | Millian Craig Stuart | Chief Operating Officer | Buy | 10,000 | $0.37 | $3.7K | 0 |
| Mar 10, 2022 | Moran Sean F. | Chief Financial Officer | Buy | 15,000 | $0.37 | $5.5K | 0 |
| Mar 9, 2022 | Cohen Yuval | Chief Executive Officer | Buy | 8,600 | $0.37 | $3.2K | 0 |
CRBP Insider Selling Activity
The following table shows recent insider sales of Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Moran Sean F. | officer: Chief Financial Officer | Sell | 12,000 | $10.08 | $121.0K | 84,694 |
| Aug 10, 2026 | Cohen Yuval | director, officer: Chief Executive Officer | Sell | 17,000 | $10.08 | $171.4K | 157,316 |
| Jun 11, 2026 | Jenkins John Kenneth | director | Sell | 4,800 | $7.91 | $38.0K | 3,833-56% |
| Jun 11, 2026 | Kung Winston | director | Sell | 2,026 | $7.91 | $16.0K | 12,140 |
| Jun 11, 2026 | Altmeyer Anne | director | Sell | 2,412 | $7.91 | $19.1K | 7,579 |
| Feb 18, 2026 | Cohen Yuval | director, officer: Chief Executive Officer | Sell | 13,871 | $7.78 | $108.0K | 174,316 |
| Feb 18, 2026 | Hodgson Ian | officer: Chief Operating Officer | Sell | 847 | $7.38 | $6.3K | 51,080 |
| Feb 18, 2026 | Moran Sean F. | officer: Chief Financial Officer | Sell | 4,701 | $7.78 | $36.6K | 96,694 |
| Feb 17, 2026 | Hodgson Ian | Chief Operating Officer | Sell | 847 | $7.38 | $6.3K | 0 |
| Feb 13, 2026 | Cohen Yuval | Chief Executive Officer | Sell | 13,871 | $7.78 | $108.0K | 0 |
| Feb 13, 2026 | Moran Sean F. | Chief Financial Officer | Sell | 4,701 | $7.78 | $36.6K | 0 |
| Feb 4, 2026 | Hodgson Ian | officer: Chief Operating Officer | Sell | 2,415 | $8.09 | $19.5K | 51,927 |
| Feb 4, 2026 | Smethurst Dominic | officer: Chief Medical Officer | Sell | 3,285 | $8.09 | $26.6K | 95,887 |
| Feb 3, 2026 | Hodgson Ian | Chief Operating Officer | Sell | 2,415 | $8.09 | $19.5K | 0 |
| Feb 3, 2026 | Smethurst Dominic | Chief Medical Officer | Sell | 3,285 | $8.09 | $26.6K | 0 |
| Oct 24, 2025 | Cohen Yuval | Chief Executive Officer | Sell | 27,633 | $17.05 | $471.2K | 0 |
| Oct 24, 2025 | Moran Sean F. | Chief Financial Officer | Sell | 12,981 | $17.02 | $220.9K | 0 |
| Oct 20, 2025 | Altmeyer Anne | Director | Sell | 1,060 | $20.50 | $21.7K | 0 |
| May 30, 2025 | Altmeyer Anne | Director | Sell | 1,392 | $7.25 | $10.1K | 0 |
| May 30, 2025 | Jenkins John Kenneth | Director | Sell | 2,783 | $7.35 | $20.5K | 0 |
| Mar 6, 2025 | Smethurst Dominic | Chief Medical Officer | Sell | 6,393 | $6.78 | $43.3K | 0 |
| Feb 14, 2025 | Cohen Yuval | Chief Executive Officer | Sell | 7,134 | $8.76 | $62.5K | 0 |
| Feb 14, 2025 | Moran Sean F. | Chief Financial Officer | Sell | 2,792 | $8.76 | $24.4K | 0 |
| Jun 14, 2024 | Cohen Yuval | Chief Executive Officer | Sell | 63,358 | $46.57 | $2.95M0.5% OS | 0 |
| Jun 14, 2024 | Moran Sean F. | Chief Financial Officer | Sell | 18,043 | $47.88 | $863.8K | 0 |
CRBP Insiders
Cohen Yuval
director, officer: Chief Executive Officer
Bought $6.8KSold $3.87M
9 tradesLast: Aug 10, 2026
Similar Stocks to CRBP
VRTX
Vertex Pharmaceuticals Incorporated
$515.77+0.17%
$132.26B
REGN
Regeneron Pharmaceuticals, Inc.
$782.89-1.28%
$83.21B
MRNA
Moderna, Inc.
$146.46+7.28%
$57.75B
RVMD
Revolution Medicines, Inc.
$204.10+0.48%
$44.15B
INSM
Insmed Incorporated
$129.20+1.54%
$27.37B
INCY
Incyte Corporation
$122.02-1.03%
$25.69B
UTHR
United Therapeutics Corporation
$497.75-1.21%
$20.70B
NBIX
Neurocrine Biosciences, Inc.
$157.15+0.37%
$15.65B